| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2020 | 2019 | 2018 | 2016 | 2015 | 2014 | 2013 | 2011 | 2010 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | 2,3 M € | -24.6% | 3,1 M € | +10.0% | 2,8 M € | -19.8% | 3,5 M € | — | — | ||||||||||||
| Gross margin | 4,7 M € | -7.8% | 5,1 M € | -10.4% | 5,7 M € | +13.7% | 5,0 M € | +0.7% | 4,9 M € | +52.2% | 3,3 M € | +553.4% | 497,6 k € | -37.6% | 797,3 k € | -26.9% | 1,1 M € | — | — | — | — | 681,3 k € | +72.0% | 396,1 k € | ||||||
| EBITDA | 337,5 k € | -45.2% | 615,9 k € | -31.5% | 899,7 k € | +24.5% | 722,3 k € | +16.6% | 619,7 k € | +28.8% | 481,2 k € | +329.5% | 112,0 k € | -34.3% | 170,6 k € | +112.3% | 80,4 k € | +0.0% | 80,3 k € | +169.5% | -115,7 k € | -134.4% | 336,0 k € | +196.6% | -347,7 k € | -745.8% | 53,8 k € | +16.9% | 46,1 k € | |
| Operating profit | -115,0 k € | -173.6% | 156,1 k € | -62.7% | 419,0 k € | +74.3% | 240,4 k € | -25.5% | 322,5 k € | +22.0% | 264,3 k € | +205.9% | 86,4 k € | -39.0% | 141,5 k € | +146.5% | 57,4 k € | -19.9% | 71,7 k € | +154.4% | -131,8 k € | -140.9% | 321,9 k € | +185.2% | -377,6 k € | -1029.0% | 40,6 k € | +12.4% | 36,2 k € | |
| Profit/loss | -208,0 k € | -663.7% | -27,2 k € | -115.0% | 181,9 k € | +101.9% | 90,1 k € | +80.9% | 49,8 k € | -64.7% | 141,2 k € | +35.2% | 104,4 k € | +33.2% | 78,4 k € | +1143.6% | 6,3 k € | +1940.3% | 309,1 € | -92.4% | 4,1 k € | -97.6% | 172,3 k € | +104.5% | -3,9 M € | -28338.5% | 13,7 k € | -31.3% | 19,9 k € | |
| Equity | 1,6 M € | -11.5% | 1,8 M € | -1.5% | 1,8 M € | +11.0% | 1,7 M € | -13.5% | 1,9 M € | -5.2% | 2,0 M € | +7.5% | 1,9 M € | +5.9% | 1,8 M € | +4.6% | 1,7 M € | +0.4% | 1,7 M € | +0.0% | 1,7 M € | +1.0% | 1,7 M € | +11.4% | 1,5 M € | +3689.6% | 39,7 k € | +52.4% | 26,1 k € | |
| Total assets | 4,1 M € | -4.2% | 4,3 M € | -10.6% | 4,8 M € | -6.0% | 5,1 M € | -1.3% | 5,1 M € | -3.5% | 5,3 M € | -21.8% | 6,8 M € | -0.9% | 6,9 M € | -12.6% | 7,9 M € | +1.9% | 7,7 M € | +12.4% | 6,9 M € | -5.9% | 7,3 M € | +15.1% | 6,3 M € | +1758.0% | 341,2 k € | +39.8% | 244,1 k € | |
| Cash | 181,0 k € | +308.2% | 44,3 k € | -90.5% | 466,3 k € | +9.1% | 427,5 k € | +278.1% | 113,1 k € | +165.7% | 42,6 k € | -79.1% | 203,6 k € | -1.6% | 207,0 k € | +200.1% | 69,0 k € | -71.7% | 243,5 k € | +11.2% | 219,1 k € | +38.8% | 157,8 k € | +88.2% | 83,8 k € | +7991.4% | 1,0 k € | -98.0% | 51,2 k € | |
| Debts | 2,3 M € | +0.2% | 2,3 M € | -17.6% | 2,8 M € | -13.5% | 3,3 M € | +5.3% | 3,1 M € | -2.4% | 3,2 M € | -34.8% | 4,9 M € | -3.6% | 5,1 M € | -17.4% | 6,2 M € | +3.0% | 6,0 M € | +21.5% | 4,9 M € | -10.5% | 5,5 M € | +16.5% | 4,7 M € | +1468.0% | 301,3 k € | +38.2% | 218,0 k € | |
| Staff | 40,4 | 46,6 | 51,4 | 47 | 49,1 | 45,2 | 6 | 8,6 | 11,9 | 9,9 | 8,2 | 11,7 | 10,1 | 7,5 | 8,8 | |||||||||||||||
Public limited company · Ternat · incorporated on 14/05/2010 · 40,4 ETP
Public limited company loss-making in the latest fiscal year. Cash position rising (+308.2%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
NOVELLAS HEALTHCARE is a Public limited company incorporated in 2010. Its main activity is: Management consultancy activities. Its registered office is in Ternat. It employs on average 40,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette